ClearBridge Investments - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2019$5,000
+25.0%
43,0000.0%0.00%
Q3 2019$4,000
-20.0%
43,0000.0%0.00%
Q2 2019$5,000
+150.0%
43,000
-36.8%
0.00%
Q1 2019$2,000
-75.0%
68,0000.0%0.00%
Q4 2018$8,000
-99.9%
68,0000.0%0.00%
-100.0%
Q3 2018$8,147,000
+10212.7%
68,0000.0%0.01%
Q2 2018$79,000
+5.3%
68,0000.0%0.00%
Q1 2018$75,000
+240.9%
68,000
+277.8%
0.00%
Q4 2017$22,0000.0%18,0000.0%0.00%
Q3 2017$22,000
+4.8%
18,0000.0%0.00%
Q2 2017$21,000
-99.2%
18,000
-99.2%
0.00%
-100.0%
Q1 2017$2,634,000
-30.9%
2,211,000
-31.1%
0.00%
-25.0%
Q4 2016$3,811,000
-5.1%
3,211,0000.0%0.00%
-20.0%
Q3 2016$4,014,000
+9.2%
3,211,0000.0%0.01%
+25.0%
Q2 2016$3,677,000
-4.2%
3,211,0000.0%0.00%
-20.0%
Q1 2016$3,837,000
-17.4%
3,211,000
-6.9%
0.01%0.0%
Q4 2015$4,646,000
+0.3%
3,450,0000.0%0.01%
-16.7%
Q3 2015$4,632,000
-14.0%
3,450,0000.0%0.01%0.0%
Q2 2015$5,386,000
+3.5%
3,450,0000.0%0.01%
+20.0%
Q1 2015$5,205,000
+3.9%
3,450,000
-15.9%
0.01%0.0%
Q4 2014$5,009,000
+11.0%
4,100,0000.0%0.01%0.0%
Q3 2014$4,514,000
+8107.3%
4,100,000
-19.6%
0.01%
Q2 2014$55,000
-98.6%
5,100,000
+41.7%
0.00%
-100.0%
Q1 2014$4,002,000
+42.9%
3,600,000
+38.5%
0.01%
+66.7%
Q4 2013$2,800,0002,600,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2014
NameSharesValueWeighting ↓
SCHRODER INVESTMENT MANAGEMENT GROUP 12,400,000$1,340,750,000,0001.66%
OAKTREE CAPITAL MANAGEMENT LP 66,800,000$70,446,0001.23%
Man Investments (CH) AG 2,600,000$2,743,0001.11%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$8,425,0000.81%
ADVENT CAPITAL MANAGEMENT /DE/ 35,763,000$38,870,0000.58%
Jabre Capital Partners S.A. 5,900,000$6,240,0000.44%
SSI INVESTMENT MANAGEMENT LLC 3,039,000$3,198,0000.31%
AVIVA PLC 37,700,000$39,724,0000.30%
BNP PARIBAS FINANCIAL MARKETS 3,000,000$315,929,984,0000.30%
Calamos Advisors LLC 44,222,000$46,596,0000.30%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders